fabrxbelieves 3D printing will shine when it comes to optimally meeting the need for age and physique-dependent medical formulations. Patient-specific dosage profiles coupled with the ability to produce polypills – multiple medications combined into single printlets – will allow for the treatment of patients with a greater degree of precision and accuracy.
这M3Dimakeris a desktop-sized FFF system specially designed to extrude medical formulae in the required doses selected by clinicians. The pharmacists operating the machine have access to sophisticated fingerprint readers incorporated into the system, allowing only qualified personnel to fabricate tablets. The addition of in-situ camera monitoring also allows for constant quality control and print failure detection.
Operators of the M3DIMAKER have the option to choose between three printing nozzles which adapt the system to different manufacturing needs, which include small batch production for clinical trials and precise personalized dosage forms for individuals. According to FabRx, the preparation of 28 printlets, or one month’s medication, takes around 8 minutes to complete depending on the drug.
Dr. Alvaro Goyanes, Director of Development at FabRx stated: “We are delighted to be launching our state-of-the-art 3D printing system in light of the recommendations from the regulatory organisations into the pharmaceutical market. I truly believe that we are one step closer to personalised medicine thanks to the M3DIMAKER.”
这3D printing of drug delivery devices has seen significant research in recent years. Released earlier in 2020, aspecial issue editorialby scientists from贝尔法斯特皇后大学详细介绍了使用各种3D打印技术的药品和药物输送设备的生产。在其他地方，专注于非常规的药物输送设备，华盛顿州立大学研究人员有3D打印了隐形眼镜竞争激光眼科手术。该镜头是能够将药物直接输送到患者眼睛的微针阵列的家园。
这nominations for the2020 3D印刷行业奖现在打开。您认为谁应该成为今年演出的入围名单？现在有你的发言权。
Looking for a career in additive manufacturing? Visit3D Printing Jobs在行业中选择一系列角色。
Featured image shows M3DIMAKER 3D printing tablets directly onto blister packaging. Photo via FabRx.